New PHE Study Determines Long-term Cancer Survivors Fare as Well or Better Than Everyone Else


Led by a team of PHE researchers, a new study appearing in the American Journal of Managed Carehas determined that long-term cancer survivors can expect health and quality of life on par with Americans of the same age and background. Those who survived cancer at least 4 years had health and well-being measures that were as good as or better than those of the general population and those with a chronic disease.

To read a summary of the findings in the AJMC’s press release, please click here.

For the full study, click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.